Home Applications 217064 Application 217064
Type NDA
Sponsor FAMYGEN LIFE SCI Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 RYZUMVI PHENTOLAMINE MESYLATE SOLUTION;OPHTHALMIC EQ 0.75% BASE Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N217064-001 RYZUMVI PHENTOLAMINE MESYLATE EQ 0.75% BASE SOLUTION / OPHTHALMIC RLD, RS 2023-09-25
Orange Book patents# Current patent rows page 1 of 1 · 11 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N217064-001 10278918 2034-01-31 Drug product 2024-02-01 N217064-001 10772829 2034-01-31 Drug product 2024-02-01 N217064-001 11090261 2034-01-31 Drug product 2024-02-01 N217064-001 11844858 2034-01-31 Drug product 2024-01-18 N217064-001 12350366 2034-01-31 Drug product 2025-07-30 N217064-001 9795560 2034-01-31 Drug product 2024-02-01 N217064-001 11400077 2039-10-25 U-3804 2024-02-01 N217064-001 12201615 2039-10-25 U-3804 2025-01-27 N217064-001 12201616 2039-10-25 U-3804 2025-01-27 N217064-001 12576066 2039-10-25 U-3804 2026-04-14 N217064-001 12576067 2039-10-25 U-3804 2026-04-14
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N217064-001 NP 2026-09-25
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217064-001 RYZUMVI EQ 0.75% BASE SOLUTION / OPHTHALMIC RLD, RS 2023-09-25 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217064-001 RYZUMVI EQ 0.75% BASE SOLUTION / OPHTHALMIC RLD, RS 2023-09-25 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217064-001 RYZUMVI EQ 0.75% BASE SOLUTION / OPHTHALMIC RLD, RS 2023-09-25 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217064-001 RYZUMVI EQ 0.75% BASE SOLUTION / OPHTHALMIC RLD, RS 2023-09-25 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217064-001 RYZUMVI EQ 0.75% BASE SOLUTION / OPHTHALMIC RLD, RS 2023-09-25 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217064-001 RYZUMVI EQ 0.75% BASE SOLUTION / OPHTHALMIC RLD, RS 2023-09-25 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217064-001 RYZUMVI EQ 0.75% BASE SOLUTION / OPHTHALMIC RLD, RS 2023-09-25 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217064-001 RYZUMVI EQ 0.75% BASE SOLUTION / OPHTHALMIC RLD, RS 2023-09-25 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217064-001 RYZUMVI EQ 0.75% BASE SOLUTION / OPHTHALMIC RLD, RS 2023-09-25 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N217064-001 RYZUMVI EQ 0.75% BASE SOLUTION / OPHTHALMIC RLD, RS 2023-09-25 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N217064-001 RYZUMVI EQ 0.75% BASE SOLUTION / OPHTHALMIC RLD, RS 2023-09-25 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N217064-001 RYZUMVI EQ 0.75% BASE SOLUTION / OPHTHALMIC RLD, RS 2023-09-25 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N217064-001 RYZUMVI EQ 0.75% BASE SOLUTION / OPHTHALMIC RLD, RS 2023-09-25 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N217064-001 RYZUMVI EQ 0.75% BASE SOLUTION / OPHTHALMIC RLD, RS 2023-09-25 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N217064-001 RYZUMVI EQ 0.75% BASE SOLUTION / OPHTHALMIC RLD, RS 2023-09-25 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N217064-001 RYZUMVI EQ 0.75% BASE SOLUTION / OPHTHALMIC RLD, RS 2023-09-25 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N217064-001 RYZUMVI EQ 0.75% BASE SOLUTION / OPHTHALMIC RLD, RS 2023-09-25 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N217064-001 RYZUMVI EQ 0.75% BASE SOLUTION / OPHTHALMIC RLD, RS 2023-09-25 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N217064-001 RYZUMVI EQ 0.75% BASE SOLUTION / OPHTHALMIC RLD, RS 2023-09-25 9b2671bbb829…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217064-001 RYZUMVI EQ 0.75% BASE SOLUTION / OPHTHALMIC RLD, RS 2023-09-25 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 3 · 119 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217064-001 10278918 2034-01-31 Drug product 2024-02-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217064-001 10772829 2034-01-31 Drug product 2024-02-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217064-001 11090261 2034-01-31 Drug product 2024-02-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217064-001 11844858 2034-01-31 Drug product 2024-01-18 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217064-001 12350366 2034-01-31 Drug product 2025-07-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217064-001 9795560 2034-01-31 Drug product 2024-02-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217064-001 11400077 2039-10-25 U-3804 2024-02-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217064-001 12201616 2039-10-25 U-3804 2025-01-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217064-001 12201615 2039-12-25 U-3804 2025-01-27 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217064-001 10278918 2034-01-31 Drug product 2024-02-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217064-001 10772829 2034-01-31 Drug product 2024-02-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217064-001 11090261 2034-01-31 Drug product 2024-02-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217064-001 11844858 2034-01-31 Drug product 2024-01-18 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217064-001 12350366 2034-01-31 Drug product 2025-07-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217064-001 9795560 2034-01-31 Drug product 2024-02-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217064-001 11400077 2039-10-25 U-3804 2024-02-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217064-001 12201616 2039-10-25 U-3804 2025-01-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217064-001 12201615 2039-12-25 U-3804 2025-01-27 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217064-001 10278918 2034-01-31 Drug product 2024-02-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217064-001 10772829 2034-01-31 Drug product 2024-02-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217064-001 11090261 2034-01-31 Drug product 2024-02-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217064-001 11844858 2034-01-31 Drug product 2024-01-18 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217064-001 12350366 2034-01-31 Drug product 2025-07-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217064-001 9795560 2034-01-31 Drug product 2024-02-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217064-001 11400077 2039-10-25 U-3804 2024-02-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217064-001 12201616 2039-10-25 U-3804 2025-01-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217064-001 12201615 2039-12-25 U-3804 2025-01-27 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217064-001 10278918 2034-01-31 Drug product 2024-02-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217064-001 10772829 2034-01-31 Drug product 2024-02-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217064-001 11090261 2034-01-31 Drug product 2024-02-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217064-001 11844858 2034-01-31 Drug product 2024-01-18 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217064-001 9795560 2034-01-31 Drug product 2024-02-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217064-001 11400077 2039-10-25 U-3804 2024-02-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217064-001 12201616 2039-10-25 U-3804 2025-01-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217064-001 12201615 2039-12-25 U-3804 2025-01-27 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217064-001 10278918 2034-01-31 Drug product 2024-02-01 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217064-001 10772829 2034-01-31 Drug product 2024-02-01 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217064-001 11090261 2034-01-31 Drug product 2024-02-01 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217064-001 11844858 2034-01-31 Drug product 2024-01-18 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217064-001 9795560 2034-01-31 Drug product 2024-02-01 b8a1b40f171c…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Ryzumvi PHENTOLAMINE MESYLATE Oyster Point Pharma, Inc. 96bb1e53-c2cc-4e60-a21a-db0269c371bf 2026-03-15 Warnings, Adverse reactions Exact identifier application applno (NDA): 217064 application number: NDA217064
Documents# Document, Submission type, Date table Document Submission type Date 77889 ORIG 2024-03-21 76684 SUPPL 2023-11-29 76673 SUPPL 2023-11-29 75567 ORIG 2023-09-26 75564 ORIG 2023-09-26